Back to top

Week In Review: Three Multinationals Plan Investments In Southeast Asia Facilities

Shanghai WuXi BiologicsĀ has broken ground on a $1.4 billion facility in Singapore. Meanwhile, Novo Nordisk announced plans to invest $556 million to expand its Tianjin city production facility.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BeiGene, Ltd. (BGNE)

Catalent, Inc. (CTLT)

Merck & Co., Inc. (MRK)

Novo Nordisk A/S (NVO)

Novartis AG (NVS)